Najafi Ramin

Avg. Two Year Performance

(59%) Avg. Purchase Return
(26%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return15%7%(10%)(60%)(59%)
Purchase Success Rate4 of 104 of 105 of 104 of 102 of 10
Average Sale Return----------
Sale Success Rate----------
Drugs » Drug Manufacturers - Other

Chief Executive Officer, Director, 10% Owner:

Holdings: 12.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--